Skip to main content
S 1126 116th Congress Senate

Concentrating on High-value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019

Official title: A bill to provide better care for Americans living with Alzheimer's disease and related dementias and their caregivers, while accelerating progress toward prev… Show full official titleShow less

Official title: A bill to provide better care for Americans living with Alzheimer's disease and related dementias and their caregivers, while accelerating progress toward prevention strategies, disease modifying treatments, and, ultimately, a cure.

Introduced: May 16, 2019 Introduced by: Capito, Shelley Moore Republican · West Virginia See on congress.gov
Health AgingHealth care coverage and accessHealth care qualityHealth information and medical records
More subjectsShow fewer subjects
Health promotion and preventive careHealth technology, devices, suppliesMedical researchMedical tests and diagnostic methodsMedicareNeurological disorders
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 10, 2019
Read twice and referred to the Committee on Finance.
Apr 10, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 10, 2019

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019

This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.

Additionally, the Centers for Medicare and Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1126: Concentrating on High-value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-1126/
MLA
"S. 1126: Concentrating on High-value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1126/.
Bluebook (legal)
S. 1126, 116th Cong. (2026), https://openamerica.io/bill/116-S-1126/.
Markdown link
[S. 1126: Concentrating on High-value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019](https://openamerica.io/bill/116-S-1126/)
Report a problem